NEW YORK (GenomeWeb News) — The Centers for Disease Control and Prevention will pay $1 million to buy eight of Advion BioSystems’ mass spectrometry-based TriVersa NanoMate units, the firm said today.
 
The systems will be used at Level One state testing sites in the Laboratory Resource Network, the CDC’s national chemical terrorism program.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.